Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 28;15:2283–2300. doi: 10.2147/IJGM.S352511

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Correlation between the expression of CXC chemokines and tumor stage in LUAD patients. The correlation between the expression of (A) CXCL1, (B) CXCL2, (C) CXCL3, (D) CXCL4, (E) CXCL5, (F) CXCL6, (G) CXCL7, (H) CXCL9, (I) CXCL10, (J) CXCL11, (K) CXCL12, (L) CXCL13, (M) CXCL14, (N) CXCL16 and (O) CXCL17 and the pathological stage of patients with LUAD. *P< 0.05.

Abbreviations: CXC, cysteine-X (any amino acid)-cysteine motif; LUAD, lung adenocarcinoma.